Antimicrobial compositions comprising esters of hydroxycarboxylic acids

US9826770B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9826770-B2
Application numberUS-90824406-A
CountryUS
Kind codeB2
Filing dateMar 10, 2006
Priority dateMar 10, 2005
Publication dateNov 28, 2017
Grant dateNov 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, a fatty alcohol ester of a hydroxycarboxylic acid, alkoxylated derivatives thereof, or combinations thereof. The compositions can also include an enhancer component, a surfactant component, a hydrophobic component, and/or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses).

First claim

Opening claim text (preview).

What is claimed is: 1. An antimicrobial composition comprising: an effective amount of an antimicrobial component comprising a (C7-C14)saturated fatty alcohol ester of a (C2-C8)hydroxycarboxylic acid, a (C8-C22)mono- or poly-unsaturated fatty alcohol ester of a (C2-C8) hydroxycarboxylic acid, an alkoxylated derivative of either of the foregoing, or combinations thereof, wherein the alkoxylated derivative has less than 5 moles of alkoxide per mole of hydroxycarboxylic acid; and the composition further comprises an effective amount of an enhancer component selected from the group consisting of alpha hydroxyacids present in an amount of at least 0.25 wt/wt %, beta hydroxyacids present in an amount of at least 0.1 wt/wt %, a chelating agent present in an amount of at least 0.1 wt/wt %, a (C1-C4)alkyl carboxylic acid present in an amount of at least 0.1 wt/wt %, a (C6-C12)aryl carboxylic acid present in an amount of at least 0.1 wt/wt %, a (C6-C12)aralkyl carboxylic acid present in an amount of at least 0.1 wt/wt %, a (C6-C12)alkaryl carboxylic acid present in an amount of at least 0.1 wt/wt %, or combinations thereof; with the proviso that the composition does not include parabens or phenoxyethanol; wherein the effective amount of the antimicrobial component in the composition is at least 0.25% by weight; wherein water is present in less than 10 wt-%, and wherein the fatty alcohol ester in the antimicrobial component is at least 70% pure. 2. The composition of claim 1 wherein the antimicrobial component comprises (C8-C12) fatty alcohol esters of glycolic acid, lactic acid, 3-hydroxybutanoic acid, or combinations thereof. 3. The composition of claim 1 further comprising a surfactant component. 4. The composition of claim 1 further comprising a hydrophilic component. 5. The composition of claim 1 having at least 3 log reduction in test bacteria in 10 minutes when evaluated by the Antimicrobial Kill Rate Test. 6. The composition of claim 3 , wherein the surfactant component does not comprise an ethoxylated sorbitan fatty acid ester. 7. The composition of claim 1 , wherein the enhancer is a chelating agent present in an amount of at least 1%. 8. The composition of claim 1 , wherein the enhancer is a chelating agent and a ratio of the concentration of the chelating agent to the antimicrobial component in the composition is within a range of 1:1 to 1:10. 9. The composition of claim 1 , wherein the fatty alcohol ester in the antimicrobial component is at least 80% pure. 10. An antimicrobial composition comprising: an effective amount of an antimicrobial component comprising a (C7-C14)saturated fatty alcohol ester of a (C2-C8)hydroxycarboxylic acid, a (C8-C22)mono- or poly-unsaturated fatty alcohol ester of a (C2-C8) hydroxycarboxylic acid, an alkoxylated derivative of either of the foregoing, or combinations thereof, wherein the alkoxylated derivative has less than 5 moles of alkoxide per mole of hydroxycarboxylic acid; and the composition further comprises an effective amount of an enhancer component selected from the group consisting of alpha hydroxyacids present in an amount of at least 0.25 wt/wt %, beta hydroxyacids present in an amount of at least 0.1 wt/wt %, a chelating agent present in an amount of at least 0.1 wt/wt %, a (C1-C4)alkyl carboxylic acid present in an amount of at least 0.1 wt/wt %, a (C6-C12)aralkyl carboxylic acid present in an amount of at least 0.1 wt/wt %, a (C6-C12)alkaryl carboxylic acid present in an amount of at least 0.1 wt/wt %, or combinations thereof; with the proviso that the composition does not include parabens or phenoxyethanol; wherein the effective amount of the antimicrobial component in the composition is at least 0.25% by weight; wherein water is present in less than 10 wt-%, and wherein the fatty alcohol ester in the antimicrobial component is at least 70% pure.

Assignees

Inventors

Classifications

  • Antimycotics · CPC title

  • Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

  • Local antiseptics · CPC title

  • Liquid substances · CPC title

  • Living organisms or biological materials · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9826770B2 cover?
Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, a fatty alcohol ester of a hydroxycarboxylic acid, alkoxylated derivatives thereof, or combinations thereof. The compositions can also include an enhancer component, a surfactant component, a hydrophobic component, and/or a hydrophilic c…
Who is the assignee on this patent?
Scholz Matthew T, Wang Danli, 3M Innovative Properties Co
What technology area does this patent fall under?
Primary CPC classification A61K31/22. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).